¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"multiple endocrine deficiency syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • lymphadenopathy syndrome
    ¸²ÇÁÀýº´(Áõ)ÁõÈıº
  • lymphoproliferative syndrome
    ¸²ÇÁ¼¼Æ÷Áõ½ÄÁõÈıº
  • middle lobe syndrome
    Áß°£¿±ÁõÈıº
  • milk-alkali syndrome
    ¿ìÀ¯¾ËÄ®¸®ÁõÈıº
  • morning glory syndrome
    ³ªÆÈ²ÉÁõÈıº
  • motor syndrome
    ¿îµ¿(ÁßÃß)ÁõÈıº
  • mucocutaneous lymph node syndrome
    Á¡¾×ÇǺθ²ÇÁÀýÁõÈıº
  • myasthenic syndrome
    ±Ù(À°)¹«·ÂÁõÈıº
  • Mallory-Weiss syndrome
    ¸»·Î¸®-¹ÙÀ̽ºÁõÈıº
  • myelodysplastic syndrome
    °ñ¼öÇü¼ºÀÌ»óÁõÈıº
  • myeloproliferative syndrome
    °ñ¼öÁõ½ÄÁõÈıº
  • myofascial pain syndrome
    ±Ù¸·ÅëÁõÁõÈıº
  • myofascial pain-dysfunction syndrome
    ±Ù¸·ÅëÁõ±â´ÉÀå¾ÖÁõÈıº
  • Marfan syndrome
    ¸¶¸£ÆÎÁõÈıº
  • maternal deprivation syndrome
    ¸ð¼º¹ÚÅ»ÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • locked-in syndrome
    °¨±ÝÁõÈıº
  • lymphadenopathy syndrome
    ¸²ÇÁÀýº´ÁõÁõÈıº
  • lymphoproliferative syndrome
    ¸²ÇÁÁõ½ÄÁõÈıº
  • malabsoption syndrome
    Èí¼öÀå¾ÖÁõÈıº
  • maladaptation syndrome
    ÀûÀÀÀå¾ÖÁõÈıº
  • maltreatment syndrome
    ÇдëÁõÈıº
  • maternal deprivation syndrome
    ¸ð¼º¹ÚÅ»ÁõÈıº
  • megacystis-megaureter syndrome
    Å«¹æ±¤Å«¿ä°üÁõÈıº
  • meningeal irritation syndrome
    ¼ö¸·ÀÚ±ØÁõÈıº
  • midsystolic click syndrome
    ¼öÃàÁß±âŬ¸¯ÁõÈıº
  • morning glory syndrome
    ³ªÆÈ²ÉÁõÈıº
  • motor syndrome
    ¿îµ¿ÁßÃßÁõÈıº
  • myasthenic syndrome
    ±ÙÀ°¹«·ÂÁõÈıº
  • myelodysplastic syndrome
    °ñ¼öÇü¼ºÀÌ»óÁõÈıº
  • myeloproliferative syndrome
    °ñ¼öÁõ½ÄÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • Marfans syndrome
    ¸¶¸£ÆÎÁõÈıº.
  • Marfans syndrome
    ¸¶¸£ÆÎ ÁõÈıº.
  • McLeod syndrome
    ¸Æ·¹¿ÀÁõÈıº
  • Melkersson-Rosenthal syndrome
    ¸áÄ¿½¼ ·ÎÁ¨Å» ÁõÈıº
  • Meniere s syndrome
    ¸Þ´Ï¿¡¸£ÁõÈıº.
  • Menieres syndrome
    ¸Þ´Ï¿¡¸£ÁõÈıº
  • Menkes (kinky) hair syndrome
    ¸àÄɾûÅ´ÅÐ ÁõÈıº
  • Menkes kinky hair syndrome
    ¸àÄÉŲ۸ðÁõÈıº
  • Mikulicz s syndrome
    ¹ÌÄð¸®ÁîÁõÈıº
  • Mikulicz s syndrome
    ¹ÌÄð¸®ÂêÁõÈıº.
  • Millard-Gubler syndrome
    ¹Ð¶ó-±Íºí·¯ÁõÈıº
  • Noonan s syndrome
    ´©³­ÁõÈıº.
  • OMS organic mental syndrome
    ±âÁú¼º Á¤½ÅÁõÈıº(Ðïòõàõïñãêñøý¦ÏØ)
  • OSAS=obstructive sleep apnea syndrome
    Æó¼â¼º ¼ö¸é ¹«È£Èí ÁõÈıº
  • Oasthouse syndrome
    ¿À¿ì½ºÆ®ÇϿ콺ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • cytochrome C oxidase deficiency
    ½ÃƮũ·Ò C ¿Á½Ã´ÙÁ¦(»êÈ­È¿¼Ò)°áÇÌ
  • cytochrome b5 reductase deficiency
    ½ÃÅäÅ©·Ò b5 ȯ¿øÈ¿¼Ò °áÇÌ
  • cytogenetic deficiency
    ¼¼Æ÷¹ß»ý°áÇÌ
  • deficiency
    °áÇÌ(Áõ)(ÌÀù¹ñø)
  • deficiency
    °áÇÌ
  • deficiency (monstrous tumor)
    °áÇÌ (±«¹°Á¾)
  • deficiency (nanismus)
    °áÇÌ(³­ÀåÀÌÁõ)
  • deficiency state, complement
    º¸Ã¼°áÇÌÁõ
  • diabetes mellitus,insulin deficiency
    Àν¶¸° °áÇÌÁõ(¡­ÌÀù¹ñø)
  • dietary deficiency
    ½ÄÀ̼º ¿µ¾ç°áÇÌ(½ÄÀ̼º¿µ¾ç°áÇÌ).
  • dietary deficiency
    ½ÄÀ̼º ¿µ¾ç°áÇÌ(ãÝìÈàõç½å×ÌÀù¹).
  • diphosphatase deficiency
    µðÆ÷½ºÆÄŸÁ¦°áÇÌ(Áõ)
  • disaccaridase deficiency
    ÀÌ´çºÐÇØÈ¿¼Ò°áÇÌ(ì£ÓØÝÂú°ý£áÈÌÀù¹)
  • disaccharidase deficiency
    ÀÌ´ç·ùºÐÇØÈ¿¼Ò°áÇÌÁõ
  • disaccharide deficiency
    ÀÌź´ç°áÇÌ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
FAMMM familial atypical multiple mole-melanoma [syndrome]
IDDM-MED insulin-dependent diabetes mellitus-multiple epiphyseal dysplasia [syndrome]
KBG syndrome of multiple abnormalities designated with the original patient's initials
MCA/MR multiple congenital anomaly/mental retardation [syndrome]
MCES medical care evaluation study; multiple cholesterol emboli syndrome
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
MCA Multiple Classification Analysis
MDR Multiple Drug Resistance
MIGET Multiple Inert Gas Elimination Technique
Min Multiple Intestinal Neoplasia
M.M. Multiple Myeloma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cracked tooth syndrome
    ±Õ¿­Ä¡ Áõ»ó, ±Õ¿­Ä¡ ÁõÈıº, ÆÄÀýÄ¡ ÁõÈıº
  • cranial nerve syndrome
    ³ú½Å°æ ÁõÈıº
  • cri du chat syndrome
    ¹¦¼º ÁõÈıº
    Á¦ 5¹ø ¿°»öüÀÇ ´Ü¿ÏÀÇ ÀϺΰ¡ °á¼ÕµÇ¾î ³ªÅ¸³ª´Â À¯Àü¼º ¼±Ãµ¼º ÁõÈıºÀ¸·Î, ¾ç¾È °Ý¸®Áõ, ¼ÒµÎÁõ, ½ÉÇÑ Á¤½Å¹Ú¾àÁõ, °í¾çÀÌ °°Àº ¿ïÀ½¼Ò¸®¸¦ Ư¡À¸·Î ÇÑ´Ù.
  • Crigler-Najjar syndrome
    Å©¸®±Û·¯-³ª¾ß ÁõÈıº
  • Crouzon syndrome
    Å©·ÎÁ¸ ÁõÈıº, Å©·çÁ¸ ÁõÈıº
    µÎ°³ ¾È¸é À̰ñÁõ, Å©·çÁ¸¾¾ Áúȯ, ¿¡ÆÛÆ® Å©·çÁ¸¾¾ ÁõÈıº µîÀÌ µ¿ÀǾî·Î ¾²À̰í ÀÖ´Ù. µÎ°³ ±âÇü, ¾È¸é Áß¾ÓºÎÀÇ Çü¼º ºÎÀü ¹× ¾èÀº ¾È¿Í·Î ÀÎÇÑ ¾È±¸ µ¹ÃâÁõÀ» Ư¡À¸·Î ÇÑ´Ù.
  • CRST syndrome
    CRST ÁõÈıº
    Calcinosis, Raynauds
  • Cushing's syndrome
    Äí½Ì ÁõÈıº
    1. ºÎ½Å ÇÇÁúÀÇ Á¾¾ç ¶Ç´Â °úÇÕ¼º¿¡ ÀÇÇØ ÄÚ¸£Æ¼Á¹ÀÌ Áö³ªÄ¡°Ô ºÐºñµÊÀ¸·Î½á »ý±ä´Ù. º¸¸§´Þ°ú °°Àº ¾ó±¼ ¸ð½À, ¾È¸é È«Á¶, ÆÄÆÈ·ÎÇü ºñ¸¸, ¼±Ãµ¼º ÇǺμ±¿°, °íÇ÷¾Ð µîÀÌ Æ¯Â¡ÀÖ´Â Áõ»óÀÌ´Ù. 2. ºÎ½Å ÇÇÁú¿¡¼­ ´çÁú ÄÚ¸£Æ¼ÄÚÀ̵尡 °ú´ÙÇÏ°Ô ºÐºñµÇ´Â º´. 1932³â ¹Ì±¹ÀÇ H. Äí½ÌÀÌ ¹ß°ßÇÏ¿´´Ù. ºÎ½Å ÇÇÁú¿¡ ¾Ç¼º ¶Ç´Â ¾ç¼ºÀÇ Á¾¾çÀÌ »ý±â°Å³ª ºÎ½Å ÇÇÁú ±× ÀÚü°¡ °ú´ÙÇÏ°Ô Áõ½ÄÇÏ´Â °æ¿ì¿¡ ³ªÅ¸³­´Ù. ºñ±³Àû µå¹® Áõ»óÀ¸·Î, 10¡­20´ë¿¡ ¸¹°í ¿©ÀÚ¿¡°Ô ¸¹´Ù. Áõ¼¼·Î´Â °íÇ÷¾Ð, ¸¸¿ù»ó ¾È¸ð
  • Cushingoid syndrome
    Äí½Ì¾ç ÁõÈıº
  • cystic duct syndrome
    ´ã³¶ °ü ÁõÈıº
  • de Clerambault syndrome
    ²ô·¹¶ûº¸¿À ÁõÈıº
  • de-toni-Debre-Fanconi syndrome
    µð-Åä´Ï-µðºê¸®-ÆÇÄÚ´Ï ÁõÈıº
  • Defibrillation syndrome
    Å»¼¶À¯¼Ò ÁõÈıº
  • deficient antibody syndrome
    Ç×ü °áÇÌ ÁõÈıº
  • deficit syndrome
    °áÇÌ ÁõÈıº
  • Demons-Meigs' syndrome
    µ¥¸ó½º-¸Þ±×½º ÁõÈıº
    ³­¼Ò ¼¶À¯Á¾À¸·Î È÷½ºÅ¸¹Î¿¡ ÀÇÇÑ ¾Æ³ªÇʶô½Ã Áõ»ó. ¼ö´ë»ç¿Í ±³Áú°èÀÇ º´º¯ ¹× Á¾¾çÀÇ È£¸£¸ó ÀÛ¿ë¿¡ ÀÇÇØ º¹¼ö¿Í Èä¼ö°¡ º´¹ßÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
folic acid deficiency anaemia Anaemia due to deficiency of folic acid, characterised by large-sized red blood cells (macrocytosis) and presence of large nuclei in erythroid precursor cells (megaloblasts) in the bone marrow.
(05 Mar 2000)
LCAT deficiency A rare condition characterised by corneal opacities, haemolytic anaemia, proteinuria, renal insufficiency, and premature atherosclerosis, and very low levels of lecithin cholesterol acyltransferase (LCAT) activity; results in accumulation of unesterfied cholesterol in plasma and tissues.
(05 Mar 2000)
lecithin acyltransferase deficiency A disease characterised by deficiency or low levels of plasma lecithin cholesterol acyl transferase. Clinical manifestations include corneal opacity, anaemia, and proteinuria.
(12 Dec 1998)
fructose-1,6-diphosphatase deficiency An autosomal recessive fructose metabolism disorder due to absent or deficient fructose-1,6-diphosphatase activity. Gluconeogenesis is impaired, resulting in accumulation of gluconeogenic precursors (e.g., amino acids, lactate, ketones) and manifested as hypoglycaemia, ketosis, and lactic acidosis. Episodes in the newborn infant are often lethal. Later episodes are often brought on by fasting and febrile infections. As patients age through early childhood, tolerance to fasting improves and development becomes normal.
(12 Dec 1998)
leukocyte adhesion deficiency An inherited disorder (autosomal recessive) in which there is a defective CD18 adherence complex that disturbs leukocyte chemotaxis. It is characterised by recurrent bacterial infections and impaired wound healing.
(05 Mar 2000)
lipoprotein lipase deficiency, familial A rare familial condition characterised by massive chylomicronaemia and decreased levels of other lipoproteins. It is due to deficiency of lipoprotein lipase, an alkaline triglyceride hydrolase which catalyses an important step in the extrahepatic removal of triglyceride-rich lipoproteins from the blood.
(12 Dec 1998)
luteal phase deficiency Inadequate function of the corpus luteum that may prevent a fertilized egg from implanting in the uterus or may lead to early pregnancy loss.
(09 Oct 1997)
Aarskog-Scott syndrome A syndrome of ocular hypertelorism, anteverted nostrils, broad upper lip, saddle-bag scrotum, and laxity of ligaments resulting in genu recurvatum, flat feet, and hyperextensible fingers; X-linked and autosomal dominant forms.
Synonym: Aarskog-Scott syndrome.
(05 Mar 2000)
Aarskog syndrome <syndrome> Grier et al. (1983) reported father and 2 sons with typical Aarskog syndrome, including short stature, hypertelorism, and shawl scrotum.
They tabulated the findings in 82 previous cases. X-linked recessive inheritance has been repeatedly suggested. The family reported by Welch (1974) had affected males in 3 consecutive generations. Thus, there is either genetic heterogeneity or this is an autosomal dominant with strong sex-influence and possibly ascertainment bias resulting from use of the shawl scrotum as a main criterion. Stretchable skin was present in the cases of Grier et al. (1983). Teebi et al. (1993) reported the case of an affected mother and 4 sons (including a pair of monozygotic twins) by 2 different husbands. They suggested that the manifestations were as severe in the mother as in the sons and that this suggested autosomal dominant inheritance. Actually, the mother seemed less severely affected, compatible with X-linked inheritance.
Clinical signs: Mild to moderate short stature,normocephaly, Widow's peak hair, maxillary hypoplasia, broad nasal bridge, anteverted nostrils, long philtrum, broad upper lip, curved linear dimple below the lower lip, hypertelorism, ptosis, down-slanted palpebral fissures, ophthalmoplegia, strabismus, hyperopic astigmatism, large cornea, floppy ears, lop-ears,cleft lip/palate, shawl scrotum, saddle-bag scrotum, cryptorchidism, brachydactyly, digital contractures, clinodactyly, mild syndactyly, transverse palmar crease, lymphoedema of the feet, ligamentous laxity, osteochondritis dissecans, proximal finger joint hyperextensibility, flexed distal finger joints, genu recurvatum, flat feet, stretchable skin, cervical spine hypermobility, odontoid anomaly, macrocytic anaemia, hemochromatosis, hepatomegaly, portal cirrhosis, imperforate anus, rectoperineal fistula, interstitial pulmonary disease, sternal deformity.
Inheritance: Sex-influenced autosomal dominant form, also X-linked form.
(05 Aug 1998)
abstinence syndrome <syndrome> A constellation of physiologic changes undergone by persons or animals who have become physically dependent on a drug or chemical due to prolonged use at elevated doses, but who are abruptly deprived of that substance. The abstinence syndrome varies with the drug to which dependence has developed. Generally the effects observed are in an opposite direction from those produced by the drug; e.g., the withdrawal syndrome from central nervous system depressants such as barbiturates and benzodiazepines consists of insomnia, restlessness, tremulousness, hallucinations, and, in the extreme, tonic-clonic convulsions which may prove fatal. The onset time and severity of the abstinence syndrome depend upon how rapidly the drug disappears from the body.
(05 Mar 2000)
Achard syndrome <syndrome> Arachnodactyly with small receding mandible, broad skull, and joint laxity limited to the hands and feet; genetics unclear.
(05 Mar 2000)
Achard-Thiers syndrome <syndrome> One form of a virilizing disorder of adrenocortical origin in women, characterised by masculinization and menstrual disorders in association with manifestations of diabetes mellitus, such as glucosuria.
(05 Mar 2000)
Achenbach syndrome <syndrome> Haematoma of the finger pad with accompanying oedema; of unknown cause in the absence of disturbances in blood coagulation mechanisms.
(05 Mar 2000)
achoo syndrome <syndrome> A disorder characterised by nearly uncontrollable paroxysms of sneezing provoked in a reflex fashion by the sudden exposure of a dark-adapted subject to intensely bright light, usually sunlight.
Inheritance: autosomal dominant.
(05 Aug 1998)
Acquired Immunodeficiency Syndrome <immunology, syndrome> An epidemic disease caused by an infection by human immunodeficiency virus (HIV-1, HIV-2), a retrovirus that causes immune system failure and debilitation and is often accompanied by infections such as tuberculosis. AIDS is spread through direct contact with bodily fluids.
Acronym: AIDS
(10 May 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
ÅëÇÕ°Ë»ö ¿Ï·á